NCT05619822

Brief Summary

Existing data suggest that both trauma and Post-Traumatic Stress Disorder (PTSD) are very common among individuals with psychosis. The presence of PTSD symptoms in psychosis is associated with worse clinical outcomes and poorer social functioning. However, PTSD is a poorly attended and poorly studied condition among this population. Research to date indicates that trauma-focused treatments are safe and effective for PTSD, even when psychotic comorbidity is present. Recent systematic reviews of psychological interventions for trauma in psychosis found that are effective in reducing trauma symptoms, suggesting that they should be implemented in front-line services. Nonetheless, larger confirmative trials are required to form robust conclusions.The aim of this project is to examine the efficacy of comprehensive third-generation protocol for people with comorbid trauma and psychosis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
May 2022Jul 2026

Study Start

First participant enrolled

May 27, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 17, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Expected
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

3.9 years

First QC Date

October 26, 2022

Last Update Submit

April 22, 2025

Conditions

Keywords

PsychosisTraumaPsychological InterventionEMDR

Outcome Measures

Primary Outcomes (4)

  • Change from posttraumatic symptoms at 12 weeks and 6 months

    International Trauma Questionnaire (ITQ; Cloitre, et al., 2018).Higher scores mean a worse outcome.

    Change baseline, 12 weeks, and 6 months

  • Change from psychotic symptoms at 12 weeks and 6 months

    Psychotic Symtoms Rating Scale (Haddock et al., 1999).Higher scores mean a worse outcome.

    Change baseline, 12 weeks, and 6 months

  • Change from psychopathological symptoms at 12 weeks and 6 months

    Symptom Checklist 45-SCL-90\_r brief (Davison et al., 1997). Higher scores mean a worse outcome.

    Change baseline, 12 weeks, and 6 months

  • Change from dissociative symptoms at 12 weeks and 6 months

    The Dissociative Experience Scale Taxon (DES-T; Waller \& Ross, 1997). Higher scores mean a worse outcome.

    Change baseline, 12 weeks, and 6 months

Secondary Outcomes (5)

  • Change from Personal and Social functioning at 12 weeks and 6 months

    Change baseline, 12 weeks, and 6 months

  • Change from Wellbeing at 12 weeks and 6 months

    Change baseline, 12 weeks, and 6 months

  • Change from satisfaction with life at 12 weeks and 6 months

    Change baseline, 12 weeks, and 6 months

  • Change from Attachment at 12 weeks and 6 months

    Change baseline, 12 weeks, and 6 months

  • Change from Emotion Regulation at 12 weeks and 6 months

    Change baseline, 12 weeks, and 6 months

Study Arms (2)

TAU + waiting list

OTHER

Treatment as usual

Behavioral: TAU

TAU + A comprehensive third-generation intervention

EXPERIMENTAL

he protocol will bedeveloped following the three stages of recovery from trauma (Herman, 2015): first, focusing on establishing the therapeutic alliance and safety; second, focusing on recounting and re-processing the traumatic event; and third, focusing on reconnecting with others and with life despite the trauma experienced. The therapy will be administered in 11 90-minute individual sessions per week, combining strategically ACT, Mindfulness, EMDR as well as Positive Psychology interventions.

Behavioral: TAU + A comprehensive third-generation intervention

Interventions

This is a individual intervention with with a total of 12 sessions: Session 1. Constructing the Therapy Experience. Session 2. Life history and immediate reactions to trauma. Session 3. Preparing to deal with trauma. Session 4. Regulating emotions. Session 5-9. Focusing on retelling and processing the traumatic event (EMDR PHASES\_PHASE 3: Evaluation of the traumatic memory. EMDR PHASE 4: Desensitization. EMDR PHASE 5: Positive Belief Installation. PHASE 6: Body Scan). Session 9. Re-evaluating traumatic memory and self-care through positive emotions. Session 10. Cultivating self-kindness. Session 11. Developing a healthy identity. Session 12. Building a better future

TAU + A comprehensive third-generation intervention
TAUBEHAVIORAL

Treatment as usual

TAU + waiting list

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be between the ages of 18 and 65 fluent enough in Spanish language;
  • Meet the criteria for a diagnosis of a psychotic spectrum disorder or a mood disorder with psychotic symptoms according to MINI (Sheeman et al., 1997);
  • Meet PTSD diagnostic criteria according to the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995)

You may not qualify if:

  • Those who have a diagnosis of substance or alcohol abuse or dependence in the 30 days prior to participation in the study
  • To have a severe neurocognitive problems or brain damage that interfere with the basic processing of information in psychotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmen Valiente

Pozuelo de Alarcón, Madrid, 28223, Spain

Location

MeSH Terms

Conditions

Psychological TraumaPsychotic DisordersWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSchizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Carmen Valiente, Ph.D.

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR
  • Regina Espinosa, Ph.D.

    Universidad Camilo Jose Cela

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2022

First Posted

November 17, 2022

Study Start

May 27, 2022

Primary Completion

April 30, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations